{"id":"https://openalex.org/W57803676","doi":null,"title":"Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.","display_name":"Onychomycosis: epidemiology, diagnosis, and treatment in a changing landscape.","publication_year":2015,"publication_date":"2015-03-01","ids":{"openalex":"https://openalex.org/W57803676","mag":"57803676","pmid":"https://pubmed.ncbi.nlm.nih.gov/25738843"},"language":"en","primary_location":{"id":"pmid:25738843","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25738843","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Theodore Rosen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodore Rosen","raw_affiliation_strings":["Baylor College of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Baylor College of Medicine","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045607626","display_name":"SF Friedlander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087384","display_name":"Rady Children's Hospital-San Diego","ror":"https://ror.org/00414dg76","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087384"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sheila Fallon Friedlander","raw_affiliation_strings":["Rady Children's Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rady Children's Hospital","institution_ids":["https://openalex.org/I4210087384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058903008","display_name":"Leon Kircik","orcid":"https://orcid.org/0000-0002-0831-2151","observed_orcids":["https://orcid.org/0000-0002-0831-2151"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leon Kircik","raw_affiliation_strings":["PLLC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PLLC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011094833","display_name":"Matthew Zirwas","orcid":"https://orcid.org/0000-0002-8380-8114","observed_orcids":["https://orcid.org/0000-0002-8380-8114"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew J Zirwas","raw_affiliation_strings":["the Ohio State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Ohio State University","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048521405","display_name":"Linda Stein Gold","orcid":"https://orcid.org/0000-0002-2758-1605","observed_orcids":["https://orcid.org/0000-0002-2758-1605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Linda Stein Gold","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107191377","display_name":"Neal D Bhatia","orcid":"https://orcid.org/0000-0001-7448-7809","observed_orcids":["https://orcid.org/0000-0001-7448-7809"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neal Bhatia","raw_affiliation_strings":["University of California at Los Angeles**"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California at Los Angeles**","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100603158","display_name":"Aditya Kumar Gupta","orcid":"https://orcid.org/0000-0002-8664-7723","observed_orcids":["https://orcid.org/0000-0002-8664-7723"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Aditya K Gupta","raw_affiliation_strings":["University of Toronto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Toronto","institution_ids":["https://openalex.org/I185261750"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.5638,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.97047168,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"14","issue":"3","first_page":"223","last_page":"33"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/onychomycosis","display_name":"onychomycosis","score":1.0},{"id":"https://openalex.org/keywords/epidemiology","display_name":"epidemiology","score":0.8899999856948853},{"id":"https://openalex.org/keywords/diagnosis","display_name":"diagnosis","score":0.9449999928474426},{"id":"https://openalex.org/keywords/antifungal-therapy","display_name":"antifungal therapy","score":0.8100000023841858},{"id":"https://openalex.org/keywords/efinaconazole","display_name":"efinaconazole","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tavaborole","display_name":"tavaborole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/topical-antifungal-agents","display_name":"topical antifungal agents","score":0.8510000109672546},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7480000257492065},{"id":"https://openalex.org/keywords/secondary-bacterial-infection","display_name":"secondary bacterial infection","score":0.8659999966621399},{"id":"https://openalex.org/keywords/tinea-corporis","display_name":"tinea corporis","score":0.8539999723434448},{"id":"https://openalex.org/keywords/tinea-cruris","display_name":"tinea cruris","score":0.8289999961853027},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.5809999704360962},{"id":"https://openalex.org/keywords/peripheral-vascular-disease","display_name":"peripheral vascular disease","score":0.8190000057220459},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.9739999771118164},{"id":"https://openalex.org/keywords/population-aging","display_name":"population aging","score":0.7960000038146973},{"id":"https://openalex.org/keywords/sports-participation","display_name":"sports participation","score":0.5529999732971191},{"id":"https://openalex.org/keywords/children","display_name":"children","score":0.7379999756813049}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9645323753356934},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.5683668851852417},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5648201107978821},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4708501696586609},{"id":"https://openalex.org/C2779617845","wikidata":"https://www.wikidata.org/wiki/Q1563808","display_name":"Superinfection","level":3,"score":0.4510575532913208},{"id":"https://openalex.org/C2780252810","wikidata":"https://www.wikidata.org/wiki/Q1455316","display_name":"Immunosuppression","level":2,"score":0.4303540289402008},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4134366810321808},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3630887567996979},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.263677179813385},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12023058533668518},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11933201551437378},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000891","descriptor_name":"Anti-Infective Agents, Local","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001896","descriptor_name":"Boron Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019999","descriptor_name":"Pharmaceutical Solutions","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:25738843","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25738843","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:57803676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25738843","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2409214810","https://openalex.org/W1643929831","https://openalex.org/W4210332095","https://openalex.org/W2637073256","https://openalex.org/W1570153192","https://openalex.org/W2078568632","https://openalex.org/W2400357792","https://openalex.org/W4306385865","https://openalex.org/W2403531495","https://openalex.org/W7212392065"],"abstract_inverted_index":{"Onychomycosis":[0],"is":[1],"an":[2,15,99],"often":[3],"overlooked":[4],"and/or":[5],"undertreated":[6],"disease.":[7],"This":[8,126],"may":[9],"be":[10],"in":[11,83,92,104],"part":[12],"due":[13],"to":[14,41,96,98],"under":[16],"appreciation":[17],"among":[18],"both":[19,105],"physicians":[20],"and":[21,30,39,73,77,81,89,107,116,133],"patients":[22],"of":[23,28,50,65,71,102,131],"its":[24],"impact":[25],"on":[26],"quality":[27],"life":[29],"the":[31,51,62,66,68,124,129],"potential":[32],"for":[33],"significant":[34],"complications,":[35],"from":[36],"tinea":[37],"corporis":[38],"cruris,":[40],"bacterial":[42],"superinfection.":[43],"Some":[44],"health":[45],"care":[46],"providers":[47],"are":[48,94],"unaware":[49],"effective":[52],"low-risk":[53],"treatments":[54],"currently":[55],"available.":[56],"Changing":[57],"demographic":[58],"characteristics":[59],"such":[60,86],"as":[61,87],"relative":[63],"aging":[64],"population;":[67],"increasing":[69],"prevalence":[70,101],"diabetes":[72],"peripheral":[74],"vascular":[75],"disease,":[76],"widespread":[78],"iatrogenic":[79],"immunosuppression;":[80],"changes":[82],"lifestyle":[84],"practices":[85],"earlier":[88],"greater":[90],"participation":[91],"sports,":[93],"likely":[95],"lead":[97],"increased":[100],"onychomycosis":[103,111],"adults":[106],"children.":[108],"Two":[109],"topical":[110],"treatments,":[112],"efinaconazole":[113],"10%":[114],"solution,":[115],"tavaborole":[117],"5%":[118],"solution":[119],"were":[120],"recently":[121],"approved":[122],"by":[123],"FDA.":[125],"article":[127],"reviews":[128],"state":[130],"knowledge":[132],"describes,":[134],"briefly,":[135],"these":[136],"new":[137],"treatment":[138],"options.":[139]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":6}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}